Three Motley Fool contributors think they've found unstoppable dividend stocks to buy right now. Here's why they picked ...

It's called Recursion OS. Using 36 petabytes (36 million gigabytes) of biological and chemical data, Recursion OS can ...

In March, a three-judge panel of the 10th Circuit Court of Appeals upheld a lower court’s ruling, issuing a unanimous decision that leaned heavily on the Unlawful Inclosures Act — a law Congress ...

Here is a close look at AppLovin stock, including where the shares of the tech company could be headed through the rest of ...

The oral formulation led to up to 12.2% weight loss over three months, a weaker outcome versus late-stage treatments from Eli ...

Shares of Rocket Pharmaceuticals, Inc. RCKT rose sharply in pre-market trading after the company disclosed that the FDA has ...

And one of the best ways to cash in on that is to invest in stocks that can exceed the market's performance. Two that look ...

Jazz Pharmaceuticals is down 9.5% since the beginning of the year, and at $112.03 per share, it is trading 22.3% below its 52-week high of $144.17 from February 2025.

Processa Pharmaceuticals is not the only stock that insiders are buying. For those who like to find small cap companies at attractive valuations, this free list of growing companies with recent ...

The Motley Fool has a disclosure policy. Why Recursion Pharmaceuticals Stock Tanked on Tuesday Person in a lab gazing into a microscope.© Getty Images ...

Image source: Getty Images. Although analysts tracking the stock were collectively modeling a lower revenue figure of $15.4 million, their net loss estimate was considerably narrower, at $0.35 per ...

Investing.com -- CASI Pharmaceuticals Inc (NASDAQ: CASI) stock surged 12.4% after the clinical-stage biopharmaceutical company announced FDA clearance of an Investigational New Drug (IND ...